IMAXIMAX
About: Imax Corp is a premier global technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers a unique end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. Top filmmakers, movie studios, artists, and creators utilize the cutting-edge visual and sound technology of IMAX to connect with audiences in innovative ways. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.
Employees: 697
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
564% more call options, than puts
Call options by funds: $42.5M | Put options by funds: $6.41M
14% more capital invested
Capital invested by funds: $657M [Q1] → $749M (+$92.3M) [Q2]
8.15% more ownership
Funds ownership: 76.7% [Q1] → 84.84% (+8.15%) [Q2]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]
7% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 55
2% less funds holding
Funds holding: 163 [Q1] → 160 (-3) [Q2]
10% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 30
Research analyst outlook
13 Wall Street Analysts provided 1 year price targets over the past 3 months
13 analyst ratings
JP Morgan David Karnovsky 67% 1-year accuracy 10 / 15 met price target | 1%upside $21 | Neutral Maintained | 14 Oct 2024 |
Roth MKM Eric Handler 88% 1-year accuracy 21 / 24 met price target | 30%upside $27 | Buy Maintained | 10 Oct 2024 |
Rosenblatt Steve Frankel 67% 1-year accuracy 22 / 33 met price target | 34%upside $28 | Buy Maintained | 4 Oct 2024 |
Barrington Research James Goss 62% 1-year accuracy 41 / 66 met price target | 15%upside $24 | Outperform Maintained | 25 Sept 2024 |
Wedbush Alicia Reese 82% 1-year accuracy 9 / 11 met price target | 25%upside $26 | Outperform Maintained | 3 Sept 2024 |
Financial journalist opinion
Based on 4 articles about IMAX published over the past 30 days